CHOP vs GEM-P in 1st Line Treatment of T-cell Lymphoma, Multicentre Phase II Study

NCT01719835 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

87

Enrollment

OTHER

Sponsor class

Conditions

Peripheral T-cell Lymphoma NOS
Anaplastic Large Cell Lymphoma, ALK-Negative
Angioimmunoblastic T-cell Lymphoma
Hepatosplenic Gamma/ Delta T-cell Lymphoma
Enteropathy-Associated T-Cell Lymphoma

Interventions

DRUG: Cyclophosphamide
DRUG: Gemcitabine
DRUG: Doxorubicin
DRUG: Vincristine
DRUG: Prednisolone
DRUG: methylprednisolone
DRUG: Cisplatin

Sponsor

Royal Marsden NHS Foundation Trust

Collaborators

[object Object]